Tim Vigers

2.1k citations

60 papers · 828 indexed · h-index 15

Impact in

Endocrinology, Diabetes and Metabolism top 2%
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
Genetics top 10%
- Diabetes and associated disorders

Papers in ⓘ

Endocrinology, Diabetes and Metabolism 35
- Diabetes Management and Research 29
- Diabetes Treatment and Management 9
Surgery 22
- Pancreatic function and diabetes 18
- Esophageal and GI Pathology 4

Co-authors: Laura Pyle (32 shared papers)Gregory P. Forlenza (13 shared papers)Christine L. Chan (15 shared papers)Laurel H. Messer (9 shared papers)Kimberly A. Driscoll (9 shared papers)Cari Berget (8 shared papers)Kristen J. Nadeau (17 shared papers)Philip Zeitler (8 shared papers)
Journals: Diabetes Technology & Therapeutics (7 papers)Diabetes (7 papers)Journal of Cystic Fibrosis (6 papers)Pediatric Diabetes (4 papers)Pediatric Pulmonology (3 papers)
Partner nations: United States Netherlands Australia

In The Last Decade

Tim Vigers

51 papers receiving 815 citations

Peers

Countries citing papers authored by Tim Vigers

Since Specialization

Citations

This map shows the geographic impact of Tim Vigers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Vigers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Vigers more than expected).

Fields of papers citing papers by Tim Vigers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Vigers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Vigers. The network helps show where Tim Vigers may publish in the future.

Co-authors

The 25 scholars most cited alongside Tim Vigers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tim Vigers Line = papers co-authored together Tim Vigers links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Real world hybrid closed‐loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months Pediatric Diabetes ·Laurel H. Messer, Cari Berget, Tim Vigers, Laura Pyle, Cristy Geno, R. Paul Wadwa, Kimberly A. Driscoll, Gregory P. Forlenza	2019	115
2	Six months of hybrid closed loop in the real‐world: An evaluation of children and young adults using the 670G system Pediatric Diabetes ·Cari Berget, Laurel H. Messer, Tim Vigers, Brigitte I. Frohnert, Laura Pyle, R. Paul Wadwa, Kimberly A. Driscoll, Gregory P. Forlenza	2019	98
3	Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline Journal of Cystic Fibrosis ·Christine L. Chan, Tim Vigers, Laura Pyle, Philip Zeitler, Scott D. Sagel, Kristen J. Nadeau	2018	59
4	cgmanalysis: An R package for descriptive analysis of continuous glucose monitor data PLoS ONE ·Tim Vigers, Christine L. Chan, Janet K. Snell‐Bergeon, Petter Bjornstad, Philip Zeitler, Gregory P. Forlenza, Laura Pyle	2019	57
5	Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes Diabetes Technology & Therapeutics ·Laurel H. Messer, Cari Berget, Laura Pyle, Tim Vigers, Erin Cobry, Kimberly A. Driscoll, Gregory P. Forlenza	2021	52
6	Hemoglobin A1c Accurately Predicts Continuous Glucose Monitoring–Derived Average Glucose in Youth and Young Adults With Cystic Fibrosis Diabetes Care ·Christine L. Chan, Emma Hope, Jessica Thurston, Tim Vigers, Laura Pyle, Philip Zeitler, Kristen J. Nadeau	2018	46
7	Continuous glucose monitoring in youth with cystic fibrosis treated with lumacaftor-ivacaftor Journal of Cystic Fibrosis ·Angel Li, Tim Vigers, Laura Pyle, Edith T. Zemanick, Kristen J. Nadeau, Scott D. Sagel, Christine L. Chan	2018	37
8	Real‐world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: Identifying a clinical target for hybrid closed‐loop use Diabetes Obesity and Metabolism ·Cari Berget, Halis Kaan Aktürk, Laurel H. Messer, Tim Vigers, Laura Pyle, Janet K. Snell‐Bergeon, Kimberly A. Driscoll, Gregory P. Forlenza	2021	33
9	Type 1 diabetes onset at young age is associated with compromised bone quality Bone ·Viral N. Shah, Prakriti Joshee, Rachel Sippl, Laura Pyle, Tim Vigers, R. Dana Carpenter, Wendy M. Kohrt, Janet K. Snell‐Bergeon	2019	29
10	Discordance Between Glucose Management Indicator and Glycated Hemoglobin in People Without Diabetes Diabetes Technology & Therapeutics ·Viral N. Shah, Tim Vigers, Laura Pyle, Peter Calhoun, Richard M. Bergenstal	2023	23
11	Clinical prediction score of nonalcoholic fatty liver disease in adolescent girls with polycystic ovary syndrome (PCOS‐HS index) Clinical Endocrinology ·Anne‐Marie Carreau, Laura Pyle, Yesenia Garcia‐Reyes, Haseeb Rahat, Tim Vigers, Thomas Jensen, Ann Scherzinger, Kristen J. Nadeau, Melanie Cree‐Green	2019	22
12	Pediatric Medicaid Patients With Type 1 Diabetes Benefit From Continuous Glucose Monitor Technology Journal of Diabetes Science and Technology ·Sonalee Ravi, Alexander Coakley, Tim Vigers, Laura Pyle, Gregory P. Forlenza, Todd Alonso	2020	19
13	The Relationship Between Continuous Glucose Monitoring and OGTT in Youth and Young Adults With Cystic Fibrosis The Journal of Clinical Endocrinology & Metabolism ·Christine L. Chan, Laura Pyle, Tim Vigers, Philip Zeitler, Kristen J. Nadeau	2021	17
14	Sodium glucose co-transporter 2 inhibition increases epidermal growth factor expression and improves outcomes in patients with type 2 diabetes Kidney International ·Taha Sen, Wenjun Ju, Viji Nair, Patricia Ladd, Rajasree Menon, Edgar A. Otto, Laura Pyle, Tim Vigers, Robert G. Nelson, Clare Arnott, Bruce Neal, Michael K. Hansen, Matthias Kretzler, Petter Bjornstad, Hiddo J.L. Heerspink	2023	16
15	Ultra Rapid-Acting Inhaled Insulin Improves Glucose Control in Patients With Type 2 Diabetes Mellitus Endocrine Practice ·Philip Levin, Byron J. Hoogwerf, Janet K. Snell‐Bergeon, Tim Vigers, Laura Pyle, Lee Bromberger	2020	15
16	Glycemia and β-cell function before and after elexacaftor/tezacaftor/ivacaftor in youth and adults with cystic fibrosis Journal of Clinical & Translational Endocrinology ·Christine L. Chan, Andrea Granados, Amir Moheet, Sachinkumar B. Singh, Tim Vigers, Ana María Arbeláez, Yaling Yi, Shanming Hu, Andrew W. Norris, Katie Larson Ode	2022	14
17	Delayed glucose peak and elevated 1-hour glucose on the oral glucose tolerance test identify youth with cystic fibrosis with lower oral disposition index Journal of Cystic Fibrosis ·Kalie L. Tommerdahl, John T. Brinton, Tim Vigers, Melanie Cree‐Green, Philip Zeitler, Kristen J. Nadeau, Christine L. Chan	2020	14
18	Screening for cystic fibrosis‐related diabetes and prediabetes: Evaluating 1,5‐anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c Pediatric Diabetes ·Kalie L. Tommerdahl, John T. Brinton, Tim Vigers, Kristen J. Nadeau, Philip Zeitler, Christine L. Chan	2019	14
19	Comparison of Cgmanalysis, a Free Open-Source Continuous Glucose Monitoring Data Management and Analysis Software, with Commercially Available CGM Platforms: Data Standardization for Diabetes Technology Research Diabetes Technology & Therapeutics ·Halis Kaan Aktürk, Tim Vigers, Gregory P. Forlenza, Anagha Champakanath, Laura Pyle	2021	11
20	Structural Lesions on Kidney Biopsy in Youth-Onset and Adult-Onset Type 2 Diabetes Diabetes Care ·Helen C. Looker, Laura Pyle, Tim Vigers, Cameron Severn, Pierre‐Jean Saulnier, Behzad Najafian, Michael Mauer, Robert G. Nelson, Petter Bjornstad	2022	10

About Tim Vigers

Tim Vigers is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Pulmonary and Respiratory Medicine, Genetics and Speech and Hearing, having authored 60 papers that have together received 828 indexed citations. Recurring topics across this work include Diabetes Management and Research (29 papers), Pancreatic function and diabetes (18 papers), Cystic Fibrosis Research Advances (15 papers), Diabetes and associated disorders (14 papers), Diabetes Treatment and Management (9 papers), Dysphagia Assessment and Management (4 papers), Tracheal and airway disorders (4 papers) and Esophageal and GI Pathology (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (573 citations), Genetics (336 citations), Surgery (390 citations), Pulmonary and Respiratory Medicine (187 citations) and Nephrology (23 citations). Tim Vigers has collaborated with scholars based in United States, Netherlands and Australia. Frequent co-authors include Laura Pyle, Gregory P. Forlenza, Christine L. Chan, Laurel H. Messer, Kimberly A. Driscoll, Cari Berget, Kristen J. Nadeau, Philip Zeitler, R. Paul Wadwa and Janet K. Snell‐Bergeon. Their work appears in journals such as Diabetes Technology & Therapeutics, Diabetes, Journal of Cystic Fibrosis, Pediatric Diabetes and Pediatric Pulmonology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact